reese headache powders

Generic: aspirin and caffeine

Labeler: reese pharmaceutical co
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name reese headache powders
Generic Name aspirin and caffeine
Labeler reese pharmaceutical co
Dosage Form POWDER
Routes
ORAL
Active Ingredients

aspirin 845 mg/1, caffeine 65 mg/1

Manufacturer
Reese Pharmaceutical Co

Identifiers & Regulatory

Product NDC 10956-501
Product ID 10956-501_59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2020-07-22

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10956501
Hyphenated Format 10956-501

Supplemental Identifiers

RxCUI
994435
UNII
R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name reese headache powders (source: ndc)
Generic Name aspirin and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 845 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 18 PACKET in 1 CARTON (10956-501-18) / 1 POWDER in 1 PACKET
  • 24 PACKET in 1 CARTON (10956-501-24) / 1 POWDER in 1 PACKET
  • 50 PACKET in 1 CARTON (10956-501-50) / 1 POWDER in 1 PACKET
source: ndc

Packages (3)

10956-501-18 18 PACKET in 1 CARTON (10956-501-18) / 1 POWDER in 1 PACKET 10956-501-24 24 PACKET in 1 CARTON (10956-501-24) / 1 POWDER in 1 PACKET 10956-501-50 50 PACKET in 1 CARTON (10956-501-50) / 1 POWDER in 1 PACKET

Ingredients (2)

aspirin (845 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

Reese Headache Powders ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["994435"], "spl_set_id": ["386f7a6c-4bfc-4140-a67b-07f6b520d58f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Reese Pharmaceutical Co"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 PACKET in 1 CARTON (10956-501-18)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-18", "marketing_start_date": "20200722"}, {"sample": false, "description": "24 PACKET in 1 CARTON (10956-501-24)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-24", "marketing_start_date": "20200722"}, {"sample": false, "description": "50 PACKET in 1 CARTON (10956-501-50)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-50", "marketing_start_date": "20200722"}], "brand_name": "Reese Headache Powders", "product_id": "10956-501_59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc", "dosage_form": "POWDER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "10956-501", "generic_name": "Aspirin and Caffeine", "labeler_name": "Reese Pharmaceutical Co", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Reese Headache Powders", "active_ingredients": [{"name": "ASPIRIN", "strength": "845 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200722", "listing_expiration_date": "20261231"}